Search

Four members of the interventional Cardiology and Vascular Section presented novel research at this year's TCT conference in Washington, DC. Their work earned BIDMC a coveted spot in the Top 10 for 2024 CRF Scientific Excellence Dr. Eric Secemsky was a featured lecturer on the subjects of peripheral...

This fall, Dr. Secemsky and Dr. Krawisz delivered a Grand Rounds presentation entitled "Confronting the Silent Killer: Advancing Complex Hypertension Care at BIDMC" in which they discussed their work in BIDMC's Complex Hypertension Clinic and how they're carving a path forward for specialized care...

Adopting Newer Clinical Guidelines Could Result In Substantial Cost Savings, Relieve ED Crowding BOSTON – An acute pulmonary embolism (PE) is a blockage of a lung artery—most often a blood clot that forms in another part of the body and travels to the lungs. A pulmonary embolism can occur suddenly...

Up To Five Percent of Medicare Beneficiaries With Pacemakers Experience Lead-Related Vein Obstructions Within Five Years of Implantation, Research Finds BOSTON – About 3 million Americans live with cardiovascular implantable electronic devices — commonly known as pacemakers. These small electronic...

The Interventional Cardiology and Vascular Research Section is ringing in the New Year with a celebration of all that its members accomplished in 2024. See the Year in Review below for a full breakdown of the many publications, presentations, and other exciting highlights from this past year.

BIDMC’s Hypertension Center Is the Region’s Only American Heart Association-Certified Comprehensive Care Center BOSTON - After her lifelong battle with an invisible adversary, Susan Mann and her physicians may finally have the upper hand against her treatment-resistant high blood pressure.

Dr. Secemsky, Dr. Krawisz, and Dr. Ferro presented at the 73rd Annual American College of Cardiology Scientific Session & Expo in Atlanta, Georgia. Fellows Dr. Joseph Kim and Dr. Nathan Watson also presented posters at the event.

In a nationwide observational study published this month in The Journal of the American Medical Association (JAMA), cardiologists from the Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center (BIDMC) were commissioned by the U.S. Food and Drug Administration (FDA) to examine

BIDMC and the Smith Center have been ranked Top 10 globally and nationally among institutions leading the way in interventional cardiovascular medicine, in recognition of their "significant contributions" to interventional cardiovascular research at the 2024 Transcatheter Cardiovascular Therapeutics...